EUVIMEDTutustu EUVIMEDiin
Systematische ÜbersichtUmbrella Review

The effects of Quercetin supplementation on cardiometabolic outcomes: An umbrella review of meta‐analyses of randomized controlled trials

Seyyed Mostafa Arabi, Mostafa Shahraki Jazinaki, Mahla Chambari, Leila Sadat Bahrami, Mohsen Maleki, Vasily N Sukhorukov, Amirhossein Sahebkar iD

Phytotherapy Research · 2023-11 · 37 (11) · 5080-5091

DOI: 10.1002/ptr.7971 ↗

At a glance

Systematische Übersicht in Phytotherapy Research, 2023-09. Written by Seyyed Mostafa Arabi and 6 co-authors. Institution: Noncommunicable Diseases Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran. Major MEDLINE topics: Cardiovascular Diseases, Insulins. Cited 15 times so far (Crossref); 32 references. Funded by: Russian Science Foundation.

TiivistelmäSubjectsBibliografiset tiedotCiteRelated studies

Abstract (original language)

Background

Quercetin is a bioactive flavonoid, but the effect of it on cardiometabolic factors has remained uncertain and previous findings from meta‐analyses have been controversial.

Objective

To provide an overview of the effects of Quercetin on cardiometabolic factors based on meta‐analyses of randomized controlled trials (RCTs).

Method

MEDLINE, SciVerse Scopus, and Clarivate Analytics Web of Science databases were searched to identify eligible publications. As part of the umbrella review, we summarized pooled estimates, 95% CIs, heterogeneity, and publication bias. A GRADE (Grading of Recommendations Assessment, Development, and Evaluation) approach was used to rate the certainty of evidence.

Results

Five meta‐analyses including 18 eligible RCTs plus 5 RCTs that were not included in previous meta‐analyses were found. The results indicated Quercetin does not affect diastolic blood pressure (DBP), lipid profile, inflammation, anthropometric indices, fasting plasma glucose (FBG), and homeostatic model assessment for insulin resistance (HOMA‐IR). However, Quercetin supplementation could significantly reduce systolic blood pressure (SBP) (weighted mean difference (WMD): −1.9, 95% CI = −3.2 to −0.6, I 2 = 88.3%) and insulin level (WMD: −1.07, 95% CI = −1.9 to −0.1, I 2 = 75.0%). The certainty of evidence ranged from very low to moderate.

Conclusion

Quercetin supplementation has reducing effects on SBP and insulin levels but not other cardiometabolic parameters. More high‐quality trials with longer follow‐up durations may be required to obtain a more robust conclusion.

Subjects

MeSH terms (MEDLINE)

Cardiovascular DiseasesInsulinsHumansDietary SupplementsQuercetinRandomized Controlled Trials as TopicMeta-Analysis as Topic

Author keywords

Quercetincardiovascular diseasediabetes mellitushypertensionmedicinal plantsphenolic compoundphytomedicine

Substances

InsulinsQuercetin

Authors and institutions

  • Noncommunicable Diseases Research Center, Neyshabur University of Medical Sciences, Neyshabur, Iran.
  • Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Department of Nutrition, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
  • Institute for Atherosclerosis Research, Moscow, Russia.
  • Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

ORCID profiles: Amirhossein Sahebkar

Funding

  • Russian Science Foundation

Cite

APA

Arabi, S. M., Shahraki Jazinaki, M., Chambari, M., Bahrami, L. S., Maleki, M., Sukhorukov, V. N., & Sahebkar, A. (2023). The effects of Quercetin supplementation on cardiometabolic outcomes: An umbrella review of meta‐analyses of randomized controlled trials. Phytotherapy Research, 37(11), 5080-5091. https://doi.org/10.1002/ptr.7971

Vancouver

Arabi SM, Shahraki Jazinaki M, Chambari M, Bahrami LS, Maleki M, Sukhorukov VN, et al. The effects of Quercetin supplementation on cardiometabolic outcomes: An umbrella review of meta‐analyses of randomized controlled trials. Phytotherapy Research. 2023;37(11):5080-5091. doi:10.1002/ptr.7971

BibTeX
@article{Arabi2023,
  author = {Arabi, Seyyed Mostafa and Shahraki Jazinaki, Mostafa and Chambari, Mahla and Bahrami, Leila Sadat and Maleki, Mohsen and Sukhorukov, Vasily N and Sahebkar, Amirhossein},
  title = {The effects of Quercetin supplementation on cardiometabolic outcomes: An umbrella review of meta‐analyses of randomized controlled trials},
  journal = {Phytotherapy Research},
  year = {2023},
  volume = {37},
  number = {11},
  pages = {5080--5091},
  doi = {10.1002/ptr.7971}
}
Start for free →